"As the Hope Heart institute finds new measures to prevent cardiovascular disease, The Hope will also continue to research methods to correct metabolic disorders without the use of drugs. These include correcting or “curing” overweight/obesity, high cholesterol, hypertension, Pre-Type 2 Diabetes, Type 2 Diabetes, and other disorders that cause cardiovascular diseases."

During the past decade, The Hope Heart Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Hope Heart Institute" are "Coronary Artery Disease" (1 trials), "Heart Failure" (1 trials) and "Hospitalized Elderly" (1 trials). Many other conditions were trialed in "The Hope Heart Institute" in a lesser frequency.

Most popular intervention types in "The Hope Heart Institute" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices" (1 trials), "Impedance Monitoring Feature" (1 trials), "Ready to Drink Flavored Beverage" (1 trials) and "Ready to drink flavored beverage w/ AN 777" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Hope Heart Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "The Hope Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Hope Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Hope Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".